5th Lipid Nanoparticles Development Summit Europe

The 5th Lipid Nanoparticles Development Summit Europe takes place on 23 and 24 September 2026 at the Dorint Kurfürstendamm in Berlin, organised by Hanson Wade. As LNPs move beyond COVID-19 vaccines into gene editing, oncology and in vivo cell therapy, the summit takes an end-to-end view from early design and intracellular delivery through analytical and CMC strategy to regulatory alignment and scalable manufacturing, spotlighting extrahepatic targeting, hybrid nanoparticle systems and strategies for repeat dosing and reduced toxicity. The event is free to attend for approved biopharma and academic delegates.